Acute Limb Ischemia among COVID-19 Patients in Hospital Kuala Lumpur
DOI:
https://doi.org/10.3889/oamjms.2022.10886Keywords:
COVID-19, Acute limb ischemia, ThromboprophylaxisAbstract
BACKGROUND: Acute arterial thromboembolism among the novel coronavirus 2019 (COVID-19) patients is worrying as it can result in significant thrombotic events.
AIM: The research aimed to determine the clinical results of COVID-19 infected patients who had ALI (acute limb ischaemia) during the COVID-19 epidemic.
METHODS: ALI patients who had a positive COVID-19 were included in the observational cohort study, which was conducted at a single centre. The primary outcomes were 30 days mortality, limb salvage, and successful revascularization.
RESULTS: From May to October 2021, data from 21 ALI subjects who had positive COVID-19 were analysed. Of the 21 included subjects, 10 were males (48%). Their mean age was 65±5 years. In nine subjects (42%), revascularization was done. Four (19%) of the 21 persons died while they were hospitalized. Twelve patients underwent major amputation and among them, one patient died after a month of hospitalization for COVID-19-related pneumonia. Among the 12 patients that underwent amputation, 10 of them presented with ALI during the first week of COVID-19 illness. Only one patient developed acute limb ischaemia despite being on heparin thromboprophylaxis.
CONCLUSION: Despite attempts at revascularization, ALI-associated with COVID-19 has high mortality and high rates of limb loss. In our experience, major amputation is required in up to a third of patients. This poor result appears to confirm that these infected individuals have a marked hypercoagulable condition. However, adhering to the treatment protocol of heparin thromboprophylaxis confers a benefit in this patient group.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Hypercoagulation and antithrombotic treatment in coronavirus 2019: A new challenge. Thromb Haemost. 2020;120(6):949-56. https://doi.org/10.1055/s-0040-1710317 PMid:32349133 DOI: https://doi.org/10.1055/s-0040-1710317
Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. https://doi.org/10.1016/j.jcv.2020.104362 PMid:32305883 DOI: https://doi.org/10.1016/j.jcv.2020.104362
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950-73. https://doi.org/10.1016/j.jacc.2020.04.031 PMid:32311448 DOI: https://doi.org/10.1016/j.jacc.2020.04.031
Etkin Y, Conway AM, Silpe J, Qato K, Carroccio A, Manvar-Singh P, et al. Acute arterial thromboembolism in patients with COVID-19 in the New York City area. Ann Vasc Surg. 2021;70:290-4. https://doi.org/10.1016/j.avsg.2020.08.085 PMid:32866580 DOI: https://doi.org/10.1016/j.avsg.2020.08.085
Llonzo N, Rao A, Safir S, Vouyouka A, Phair J, Baldwin M, et al. Acute thrombotic manifestations of coronavirus disease 2019 infection: Experience at a large New York City health care system. J Vasc Surg. 2021;73(3):789-96. https://doi.org/10.1016/j.jvs.2020.08.038 PMid:32882350
Indes JE, Koleilat I, Hatch AN, Choinski K, Jones DB, Aldailami H, et al. Early experience with arterial thromboembolic complications in patents with COVID-19. J Vasc Surg. 2021;73(2):381-9. https://doi.org/10.1016/j.jvs.2020.07.089 PMid:32861865 DOI: https://doi.org/10.1016/j.jvs.2020.07.089
Bellosta R, Luzzani L, Natalini G, Pegorer MA, Attisani L, Cossu LG, et al. Acute limb ischaemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020;72(6):1864-72. https://doi.org/10.1016/j.jvs.2020.04.483 PMid:32360679 DOI: https://doi.org/10.1016/j.jvs.2020.04.483
Baril DT, Ghosh K, Rosen AB. Trends in the incidence, treatment, and outcomes of acute lower extremity ischaemia in the United States Medicare population. J Vasc Surg. 2014;60(3):669-77. https://doi.org/10.1016/j.jvs.2014.03.244 PMid:24768362 DOI: https://doi.org/10.1016/j.jvs.2014.03.244
Eliason JL, Wainess RM, Proctor MC, Dimick JB, Cowan JA Jr., Upchurch GR Jr., et al. A national and single institutional experience in the contemporary treatment of acute lower extremity ischaemia. Ann Surg. 2003;238(3):382-90. https://doi.org/10.1097/01.sla.0000086663.49670.d1 PMid:14501504 DOI: https://doi.org/10.1097/01.sla.0000086663.49670.d1
Hemingway J, Emanuels D, Aarabi S, Quiroga E, Tran N, Starnes B, et al. Safety of transfer, type of procedure, and factors predictive of limb salvage in a modern series of acute limb ischaemia. J Vasc Surg. 2019;69(4):1174-9. https://doi.org/10.1016/j.jvs.2018.08.174 PMid:30777685 DOI: https://doi.org/10.1016/j.jvs.2018.08.174
Bissacco D, Grassi V, Lomazzi C, Domanin M, Bellosta R, Piffaretti G, et al. Is there a vascular side of the story? Vascular consequences during COVID-19 outbreak in Lombardy, Italy. J Card Surg. 2020;36(5):1677-82. https://doi.org/10.1111/jocs.15069 PMid:33012015 DOI: https://doi.org/10.1111/jocs.15069
Galyfos G, Sianou A, Frountzas M, Vasilios K, Vouros D, Theodoropoulos C, et al. Acute limb ischaemia among patients with COVID-19 infection. J Vasc Surg. 2022;75(1):326-42. https://doi.org/10.1016/j.jvs.2021.07.222 PMid:34390791 DOI: https://doi.org/10.1016/j.jvs.2021.07.222
Van Paassen J, Vos JS, Hoekstra EM, Neumann KM, Boot PC, Arbous SM. Corticosteroid use in COVID-19 patients: A systematic review and meta-analysis on clinical outcomes. Crit Care. 2020:24(1):696. https://doi.org/10.1186/s13054-020-03400-9 PMid:33317589 DOI: https://doi.org/10.1186/s13054-020-03400-9
Russell MW, Taylor DC, Cummins G, Huse DM. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients. Am J Manag Care. 2002;8(1 suppl):S3-9. PMid:11822347
Yale SH, Medlin SC, Liang H, Peters T, Glurich I, Mazza JJ. Risk assessment model for venothromboembolism in post-hospitalized patients. Int Angiol. 2005;24(3):250-4. PMid:16158034
Huerta C, Johansson S, Wallander MA, Rodríguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med. 2007;167(9):935-43. https://doi.org/10.1001/archinte.167.9.935 PMid:17502535 DOI: https://doi.org/10.1001/archinte.167.9.935
Squizzato A, Gerdes VE, Ageno W, Büller HR. The coagulation system in endocrine disorders: A narrative review. Intern Emerg Med. 2007;2(2):76-83. https://doi.org/10.1007/s11739-007-0026-X PMid:17657422 DOI: https://doi.org/10.1007/s11739-007-0026-X
Ilonzo N, Rao A, Safir S, Vouyouka A, Phair J, Baldwin M, et al. Acute thrombotic manifestations of coronavirus disease 2019 infection: Experience at a large New York City health care system. J Vasc Surg. 2021;73(3):789-96. https://doi.org/10.1016/j.jvs.2020.08.038 PMid:32882350 DOI: https://doi.org/10.1016/j.jvs.2020.08.038
Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):206. https://doi.org/10.1186/s12967-020-02374-0 DOI: https://doi.org/10.1186/s12967-020-02374-0
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9. https://doi.org/10.1111/jth.14817 PMid:32220112 DOI: https://doi.org/10.1111/jth.14817
Downloads
Published
How to Cite
License
Copyright (c) 2022 Karthigesu Aimanan, Nurul Nadiah Nazurah Mohd Ali, Mohd Nurhisham Azmi Abdul Rahman, Putra Mas Pian, Kumaraguru V.K. Pillay, Firdaus Hayati, Hanif Hussein (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
